Improvement of markers endothelial damage in patients with pulmonary arterial hypertension (PAH) related to systemic sclerosis (SSC) after bosentan treatment.

被引：0
|
作者：
Del Papa, N
Cortiana, M
Comina, D
Maglione, W
Silvestris, I
Manara, M
Maresta, A
Cortelezzi, A
机构：
[1] Ist Ortoped Gaetano Pini, Milan, Italy
[2] IRCCS, Osped Maggiore, Milan, Italy
[3] Univ Milan, Milan, Italy
[4] Pharmaceut Italy, Imola, Italy
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [1] Effect of bosentan treatment on survival of patients with pulmonary arterial hypertension related to systemic sclerosis (PAH-SSc)
    Denton, CP
    Black, CM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 108 - 108
  • [2] Protective effect of Bosentan on vascular endothelium in patients with pulmonary arterial hypertension (PAH) related to systemic sclerosis
    Del Papa, N
    Cortiana, M
    Comina, DP
    Maglione, W
    Manara, M
    Vitali, C
    Fracchiolla, N
    Cortelezzi, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 299 - 299
  • [3] Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)
    Jiang, Yuxuan
    Turk, Matthew A.
    Pope, Janet E.
    [J]. AUTOIMMUNITY REVIEWS, 2020, 19 (09)
  • [4] Long term treatment with bosentan for pulmonary arterial hypertension related to systemic sclerosis
    Cozzi, F
    Montisci, R
    Marotta, H
    Bobbo, F
    Favaro, M
    Tiso, F
    Ciprian, L
    Iliceto, S
    Todesco, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 297 - 297
  • [5] Treatment of severe pulmonary arterial hypertension related to systemic sclerosis: Experience with bosentan
    Ahmadi-Slmab, K
    Hellmich, B
    Gross, WL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294
  • [6] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    [J]. ALLERGY, 2008, 63 : 353 - 353
  • [7] Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
    Vincent Sobanski
    David Launay
    Eric Hachulla
    Marc Humbert
    [J]. Current Rheumatology Reports, 2016, 18
  • [8] Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
    Sobanski, Vincent
    Launay, David
    Hachulla, Eric
    Humbert, Marc
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (02) : 1 - 14
  • [9] Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
    Argula, Rahul G.
    Ward, Celine
    Feghali-Bostwick, Carol
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 1427 - 1442
  • [10] OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)
    Chin, Kelly
    Kim, Nick
    Channick, Richard
    Rouzic, Erwan Muros-Le
    Selej, Mona
    McLaughlin, Vallerie
    [J]. CHEST, 2017, 152 (04) : 999A - 1000A
12345